ABSTRACT NUMBER: ESOC2026A178 TARGET MISMATCH CRITERIA IN ACUTE ISCHEMIC STROKE PATIENTS WITH DISTAL-MEDIUM VESSEL OCCLUSION Authors: Giorgio Busto, Andrea Morotti, Ilaria Casetta, Francesco Arba, Guido Fanfani, Francesco Impagliazzo, Francesco Loverre, Andrea Ginestroni, Umberto Pensato, Alessandro Padovani, Enrico Fainardi Published: 2026 ABSTRACT AbstractBackground and aimsThe efficacy of endovascular treatment in ischemic stroke patients with distal-medium vessel occlusion (DMVO) remains unclear. We evaluated whether CT-perfusion target mismatch criteria (TMC) could predict functional independence in patients with M2 non- or codominant middle cerebral artery DMVO.MethodsConsecutive patients with DMVO receiving EVT and imaged with multimodal CT study protocol within 24h from onset were analyzed. A receiver operating characteristic curve analysis was used to identify the infarct core volume cutoff to predict functional independence (modified Rankin Scale 0–2 at 3-months). This parameter was subsequently considered as part of TMC together with penumbra volume⩾10mL and mismatch ratio ⩾1.2. The association between TMC and functional independence was tested with logistic regression.ResultsA total of 115 patients with DMVO were included. Infarct core volume had good discriminative ability for functional independence (AUC 0.75; 95%CI 0.64–0.84) and the best cut-off value was ⩽30mL (77% sensitivity, 61% specificity). TMC were independently associated with functional independence (OR [odds ratio]=6.50, 95%CI=2.37–17.77, p<0.001), excellent outcome (modified Rankin scale 0–1 at 3-months, OR=3.28, 95%CI=1.30–8.31, p=0.012) and final infarct volume (B=−35.52, p=0.004). After including interaction terms, a significant treatment effect on functional independence was observed between successful recanalization and TMC (OR=3.82, 95%CI=1.64–8.89, p=0.002).ConclusionsIn patients with M2 non- or codominant DMVO receiving EVT, TMC identified as core volume ⩽30 mL, penumbra volume ⩾ 10 mL, and mismatch ratio ⩾ 1.2, were associated with better functional outcome.Conflict of interestGiorgio Busto, MD: nothing to disclose